10/30/2024
6:33 AM | Summit Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2024
6:06 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
4:08 PM | Clark Kenneth A (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:54 PM | Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
4:28 PM | Summit Therapeutics (Filer)
| Form S-3ASR | |
09/13/2024
6:29 PM | Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
5:25 PM | DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/13/2024
4:54 PM | DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
| Form SC 13D/A | |
09/13/2024
4:40 PM | Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:26 PM | Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:29 PM | Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
5:49 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
6:23 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:14 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:37 AM | Summit Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/27/2024
4:20 PM | Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:16 PM | Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/27/2024
3:27 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
4:14 PM | Summit Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/17/2024
4:25 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
1:03 PM | Summit Therapeutics (Filer)
| Form DEFA14A | |
06/03/2024
5:18 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
5:05 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
3:48 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
7:35 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
7:03 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:48 AM | Summit Therapeutics (Filer)
| Form 424B5 | |
05/01/2024
7:45 AM | Summit Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/01/2024
7:18 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
7:11 AM | Summit Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/15/2024
8:21 AM | Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
8:19 AM | Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/11/2024
3:35 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
4:52 PM | Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
4:43 PM | Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:47 PM | Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
3:42 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
7:27 PM | Dhingra Ankur (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
7:28 PM | Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
7:07 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
7:36 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Is Starlink Set For The Largest IPO In History? (Ad) He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant.
Then, he did it again with Tesla… which is up more than 19,500% since 2010.
For perspective, that turns $100 invested into almost $20,000! Click here now for the urgent details. |
02/27/2024
11:15 PM | Summit Therapeutics (Filer)
| Form EFFECT | |
02/20/2024
6:55 AM | Summit Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/20/2024
7:05 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
6:32 AM | Summit Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
4:25 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:35 PM | Summit Therapeutics (Issuer)
Xia Yu (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/08/2024
3:08 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
8:07 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:19 PM | Summit Therapeutics (Issuer)
Xia Yu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:22 PM | Mahatme Ujwala (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:24 PM | Clark Kenneth A (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:16 PM | DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
